{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:04:38Z","timestamp":1784664278845,"version":"3.55.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Uterine diffuse large B-cell lymphoma (DLBCL) is a rare clinical condition. Most studies for uterine DLBCL are derived from case reports and series. Our main objective was to present a new case while also investigating the demographic, clinical characteristics, and survival of women with primary uterine DLBCL as compared to non-uterine DLBCL using the Surveillance, Epidemiology, and End Results incidence database. We queried the Surveillance, Epidemiology, and End Results database for women aged 18\u200ayears or older with a diagnosis of primary DLBCL from 1975 to 2017. The most common site of primary uterine DLBCL is the cervix uteri not otherwise specified, followed by endometrium, uterus not otherwise specified, corpus uteri, myometrium and isthmus uteri. Non-uterine DLBCL cases tend to be older than uterine DLBCL cases. Uterine DLBCL is most common among women aged 40 to 64\u200ayears. Patients with uterine DLBCL showed greater survival than non-uterine DLBCL patients, and patients treated in the rituximab era also exhibited a survival benefit. Both the elderly and African American cohorts experienced worse overall survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027359","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T13:28:52Z","timestamp":1633699732000},"page":"e27359","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Primary diffuse large B-cell lymphoma of the uterus"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-7866","authenticated-orcid":false,"given":"Allyne M.","family":"Ensor","sequence":"first","affiliation":[{"name":"William Carey University College of Medicine, Hattiesburg, MS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-8154","authenticated-orcid":false,"given":"Cesar Gentille","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Houston Methodist Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3533-4388","authenticated-orcid":false,"given":"Joe E.","family":"Ensor","sequence":"additional","affiliation":[{"name":"Houston Methodist Cancer Center, Houston, TX"},{"name":"Houston Methodist Research Institute, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-1443","authenticated-orcid":false,"given":"Kartik","family":"Anand","sequence":"additional","affiliation":[{"name":"Callahan Cancer Center, Great Plains Health, North Platte, NE."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fonc.2019.00107","article-title":"Dysregulation of cell survival in diffuse large B cell lymphoma: mechanisms and therapeutic targets","volume":"9","author":"Miao","year":"2019","journal-title":"Front Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"07","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R5-20250504","first-page":"4377","article-title":"Primary diffuse large B-cell lymphoma of the uterus: case report and review","volume":"34","author":"Mandato","year":"2014","journal-title":"Anticancer Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","DOI":"10.1111\/j.1525-1438.2006.00747.x","article-title":"Non-Hodgkin's lymphoma mimicking gynecological malignancies of the vagina and cervix: a report of four cases","volume":"17.","author":"Cohn","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00277-007-0328-0","article-title":"Primary follicular lymphoma of the cervix uteri: a review","volume":"86","author":"Korcum","year":"2007","journal-title":"Ann Hematol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2017.02.043","article-title":"Primary lymphoma of the female genital tract: an analysis of 697 cases","volume":"145","author":"Nasioudis","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1080\/10428190600687653","article-title":"Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literature","volume":"47","author":"Frey","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1097\/01.pgp.0000183049.30212.f9","article-title":"Lymphoma of the female genital tract: current status","volume":"25","author":"Lagoo","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1634\/theoncologist.2014-0113","article-title":"Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis","volume":"19","author":"Hamlin","year":"2014","journal-title":"Oncologist"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.18203\/2320-1770.ijrcog20174076","article-title":"Case of extranodal non-hodgkins lymphoma involving the endometrium and the ovaries: a rare case report","volume":"6","author":"Malempati","year":"2017","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"R13-20250504","first-page":"3042531","article-title":"Case report of diffuse large B cell lymphoma of uterine cervix treated at a semiurban cancer centre in North India","volume":"2016","author":"Sharma","year":"2016","journal-title":"Case Rep Hematol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/OTT.S78171","article-title":"Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature","volume":"8","author":"Chen","year":"2015","journal-title":"Onco Targets Ther"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00277-013-2003-y","article-title":"Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse","volume":"93","author":"Cao","year":"2014","journal-title":"Ann Hematol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/bjh.14325","article-title":"Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement","volume":"175","author":"El-Galaly","year":"2016","journal-title":"Br J Haematol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/jcp.18.6.723","article-title":"Primary malignant lymphoma of the uterus","volume":"18","author":"Fox","year":"1965","journal-title":"J Clin Pathol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/0973-1482.52784","article-title":"Diffuse large B-cell lymphoma of the uterine cervix: a rare case managed novelly","volume":"5","author":"Baijal","year":"2009","journal-title":"J Cancer Res Ther"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1159\/000334852","article-title":"Primary malignant lymphoma of the uterus: a case report and review of the literature","volume":"4","author":"Samama","year":"2011","journal-title":"Case Rep Oncol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/modpathol.3880005","article-title":"Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases","volume":"13","author":"Vang","year":"2000","journal-title":"Mod Pathol"},{"key":"R22-20250504","first-page":"298","article-title":"Primary cervical and uterine corpus lymphoma; a case report and literature review","volume":"6","author":"Anagnostopoulos","year":"2013","journal-title":"Int J Clin Exp Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/01.pas.0000178089.77018.a9","article-title":"Lymphomas of the female genital tract: a study of 186 cases and review of the literature","volume":"29","author":"Kosari","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience","volume":"34","author":"Salles","year":"2017","journal-title":"Adv Ther"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J Clin Oncol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"e6846","DOI":"10.1097\/MD.0000000000006846","article-title":"Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: a case report","volume":"96","author":"Cubo","year":"2017","journal-title":"Medicine"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:33:12Z","timestamp":1746340392000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027359"}},"subtitle":["A SEER database analysis"],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":26,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027359","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"assertion":[{"value":"2020-11-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}